NMR structural characterization of the penta-peptide calpain inhibitor

FEBS Letters

Volumn 583, Issue 1, 2009, Pages 135-140

  Deshmukh, Lalit ^a   Wu, Liping ^a   Guttmann, Rodney P ^b   Vinogradova, Olga ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Calmodulin like domain (CaMLD); Calpain inhibitor; Calpastatin; Cyclo peptide; Modeling; NMR

Indexed keywords

CALMODULIN; CALPASTATIN; CALPASTATIN LSEAL; DOCKING PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL STRUCTURE; CONTROLLED STUDY; ENZYME ACTIVE SITE; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN DOMAIN;

AMINO ACID SEQUENCE; BINDING SITES; CALMODULIN; GLYCOPROTEINS; HUMANS; MOLECULAR SEQUENCE DATA; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; OLIGOPEPTIDES; PROTEIN CONFORMATION;

EID: 57749181289     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2008.11.037     Document Type: Article

References (27)

1. Goll D.E., Thompson V.F., Li H., Wei W., and Cong J. The calpain system. Physiol. Rev. 83 (2003) 731-801
2. Guttmann R.P., Elce J.S., Bell P.D., Isbell J.C., and Johnson G.V. Oxidation inhibits substrate proteolysis by calpain I but not autolysis. J. Biol. Chem. 272 (1997) 2005-2012
3. Dutt P., Arthur J.S., Croall D.E., and Elce J.S. M-calpain subunits remain associated in the presence of calcium. FEBS Lett. 436 (1998) 367-371
4. Bartus R.T., Elliott P.J., Hayward N.J., Dean R.L., Harbeson S., Straub J.A., Li Z., and Powers J.C. Calpain as a novel target for treating acute neurodegenerative disorders. Neurol. Res. 17 (1995) 249-258
5. Wang K.K. Calpain and caspase: can you tell the difference? by Kevin K.W. Wang, vol. 23, pp. 20-26. Trends Neurosci 23 (2000) 59
6. Moldoveanu T., Hosfield C.M., Lim D., Elce J.S., Jia Z., and Davies P.L. A Ca(2+) switch aligns the active site of calpain. Cell 108 (2002) 649-660
7. Guttmann R.P., Day III G.A., Wang X., and Bottiggi K.A. Identification of a novel calpain inhibitor using phage display. Biochem. Biophys. Res. Commun. 333 (2005) 1087-1092
8. McCollum A.T., Jafarifar F., Lynn B.C., Agu R.U., Stinchcomb A.L., Wang S., Chen Q., and Guttmann R.P. Inhibition of calpain-mediated cell death by a novel peptide inhibitor. Exp. Neurol. 202 (2006) 506-513
9. Maki M., Takano E., Mori H., Sato A., Murachi T., and Hatanaka M. All four internally repetitive domains of pig calpastatin possess inhibitory activities against calpains I and II. FEBS Lett. 223 (1987) 174-180
10. Todd B., Moore D., Deivanayagam C.C., Lin G.D., Chattopadhyay D., Maki M., Wang K.K., and Narayana S.V. A structural model for the inhibition of calpain by calpastatin: crystal structures of the native domain VI of calpain and its complexes with calpastatin peptide and a small molecule inhibitor. J. Mol. Biol. 328 (2003) 131-146
11. Yang H.Q., Ma H., Takano E., Hatanaka M., and Maki M. Analysis of calcium-dependent interaction between amino-terminal conserved region of calpastatin functional domain and calmodulin-like domain of mu-calpain large subunit. J. Biol. Chem. 269 (1994) 18977-18984
12. K. Wuthrich, NMR of Proteins and Nucleic Acids, John Wiley & Sons, New York (1986).
13. Nilges M., Clore G.M., and Gronenborn A.M. Determination of three-dimensional structures of proteins from interproton distance data by hybrid distance geometry-dynamical simulated annealing calculations. FEBS Lett. 229 (1988) 317-324
14. A.T. Brunger, Yale University, New Haven, CT, (1993).
15. 1H nuclear magnetic resonance and distance geometry. J. Mol. Biol. 182 (1985) 295-315
16. Clore G.M., Nilges M., Sukumaran D.K., Brunger A.T., Karplus M., and Gronenborn A.M. The three-dimensional structure of a1-purothionin in solution: combined use of nuclear magnetic resonance, distance geometry and restrained molecular dynamics. EMBO J. 5 (1986) 2729-2735
17. Laskowski R.A., MacArthur M., Moss D.S., and Thornton J.M. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 26 (1993) 283-291
18. Torda A.E., Scheek R.M., and van Gunsteren W.F. Time-averaged nuclear Overhauser effect distance restraints applied to tendamistat. J. Mol. Biol. 214 (1990) 223-235
19. Bates P.A., Kelley L.A., MacCallum R.M., and Sternberg M.J. Enhancement of protein modeling by human intervention in applying the automatic programs 3D-JIGSAW and 3D-PSSM. Proteins 5 Suppl. (2001) 39-46
20. de Vries S.J., van Dijk A.D., Krzeminski M., van Dijk M., Thureau A., Hsu V., Wassenaar T., and Bonvin A.M. HADDOCK versus HADDOCK: new features and performance of HADDOCK2.0 on the CAPRI targets. Proteins 69 (2007) 726-733
21. Clore G.M., and Gronenborn A.M. The two-dimensional transferred nuclear Overhauser effect. J. Magn. Reson. 48 (1982) 402-417
22. Vaynberg J., and Qin J. Weak protein-protein interactions as probed by NMR spectroscopy. Trend Biotechnol. 24 (2006) 22-27
23. Huang X., and Miller W. A time-efficient, linear-space local similarity algorithm. Adv. Appl. Math. 12 (1991) 337-357
24. Schwieters C.D., and Clore G.M. The VMD-XPLOR visualization package for NMR structure refinement. J. Magn. Reson. 149 (2001) 239-244
25. W.L. DeLano, DeLano Scientific LLC, Palo Alto, CA, USA, (2008).
26. Koradi R., Billeter M., and Wuthrich K. MOLMOL: a program for display and analysis of macromolecular structures. J. Mol. Graph. 14 51-55 (1996) 29-32
27. Guttmann R.P., Day III G.A., Wang X., and Bottiggi K.A. Identification of a novel calpain inhibitor using phage display. Biochem. Biophys. Res. Commun. 333 (2005) 1087-1092